Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-13

AUTHORS

Iman Saber, Andrew Milewski, Allen B Reitz, Scott M Rawls, Ellen A Walker

ABSTRACT

RATIONALE: The underlying pharmacological mechanisms of mephedrone, especially as related to interactions with different neurotransmitter systems, are a critical area of study as mephedrone continues to be abused. OBJECTIVE: Direct-acting 5-HT2A/2C receptor agonists and antagonists and D1-3 receptor antagonists were examined in two groups of rats trained to discriminate mephedrone. A high dose of mephedrone was trained to extend previous results with traditional monoamine transporter inhibitors and substrate releasers. A very low dose of mephedrone was trained to preferentially capture serotonergic activity and to minimize the influence of rate-decreasing effects on substitution patterns. Selective 5-HT2A/2C and D1-3 receptor antagonists were examined in both groups. METHODS: Male Sprague-Dawley rats were trained to discriminate either a low dose of 0.5 mg/kg mephedrone (N = 24) or a high dose of 3.2 mg/kg mephedrone (N = 11) from saline. RESULTS: In the low training-dose group, mephedrone, MDMA, methamphetamine, d-amphetamine, cocaine, and enantiomers of mephedrone substituted for mephedrone; mCPP partially substituted overall for mephedrone; and DOI, WAY163909, and morphine failed to substitute for mephedrone. In the high training-dose group, only mephedrone and MDMA substituted for mephedrone. Sulpiride produced a small antagonism of the low training dose of mephedrone while SCH23390, SB242084, and ketanserin altered response rates. CONCLUSIONS: A lower training dose of mephedrone produces a discriminative stimulus fully mimicked by MDMA, methamphetamine, cocaine, and d-amphetamine, whereas a higher training dose of mephedrone requires a discriminative stimulus that was only mimicked by MDMA. Dopaminergic or serotoninergic antagonists failed to produce significant blockade of mephedrone at either training dose. More... »

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00213-019-05241-z

DOI

http://dx.doi.org/10.1007/s00213-019-05241-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113380414

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30980094


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Temple University", 
          "id": "https://www.grid.ac/institutes/grid.264727.2", 
          "name": [
            "Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA, 19140, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saber", 
        "givenName": "Iman", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Temple University", 
          "id": "https://www.grid.ac/institutes/grid.264727.2", 
          "name": [
            "Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA, 19140, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Milewski", 
        "givenName": "Andrew", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Fox Chase Chemical Diversity Center", 
          "id": "https://www.grid.ac/institutes/grid.421568.c", 
          "name": [
            "Fox Chase Chemical Diversity Center, Inc., Doylestown, PA, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reitz", 
        "givenName": "Allen B", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Temple University", 
          "id": "https://www.grid.ac/institutes/grid.264727.2", 
          "name": [
            "Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.", 
            "Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rawls", 
        "givenName": "Scott M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Temple University", 
          "id": "https://www.grid.ac/institutes/grid.264727.2", 
          "name": [
            "Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA, 19140, USA. ellen.walker@temple.edu.", 
            "Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. ellen.walker@temple.edu."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walker", 
        "givenName": "Ellen A", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0969-8051(02)00306-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003130359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2012.04.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003806071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1037/1064-1297.8.3.415", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008053491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00213-012-2855-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015284260", 
          "https://doi.org/10.1007/s00213-012-2855-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0b013e328364166d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017968100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0b013e328364166d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017968100"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02244073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020914677", 
          "https://doi.org/10.1007/bf02244073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02244073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020914677", 
          "https://doi.org/10.1007/bf02244073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00213-015-4142-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024575806", 
          "https://doi.org/10.1007/s00213-015-4142-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.euroneuro.2014.04.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024896051"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2015.01.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028679944"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.euroneuro.2011.07.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030590514"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002130050622", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034947421", 
          "https://doi.org/10.1007/s002130050622"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2015.08.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035248661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2999(94)90690-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037141728"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0014-2999(94)90690-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037141728"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.2011.01499.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037674586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/adb.12399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038449511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bcp.2013.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038605497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.euroneuro.2014.12.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038862287"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0091-3057(03)00029-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040651277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/jpet.111.184119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042124366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bcp.2014.01.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042885818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/npp.2011.304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044856319", 
          "https://doi.org/10.1038/npp.2011.304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90424-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045071163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90424-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045071163"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bph.13030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046444836"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1476-5381.2012.02145.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050947391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3762/bjoc.8.194", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071380882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4303/jdar/236009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072445071"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1523/jneurosci.15-02-01308.1995", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082543491"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/7854_2017_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084506667", 
          "https://doi.org/10.1007/7854_2017_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/7854_2017_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084506667", 
          "https://doi.org/10.1007/7854_2017_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/7854_2017_5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084506667", 
          "https://doi.org/10.1007/7854_2017_5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2017.04.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084533479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2017.04.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086021993"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2017.04.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1086021993"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090659426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000328", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090659426"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2017.07.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090903492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.neuropharm.2017.07.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090903492"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00213-017-4716-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091221773", 
          "https://doi.org/10.1007/s00213-017-4716-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00213-017-4716-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091221773", 
          "https://doi.org/10.1007/s00213-017-4716-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/acschemneuro.7b00212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091615896"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106913628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106913628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106913628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106913628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/fbp.0000000000000442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106913628"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/164_2018_178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109757023", 
          "https://doi.org/10.1007/164_2018_178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/164_2018_178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109757023", 
          "https://doi.org/10.1007/164_2018_178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/164_2018_178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109757023", 
          "https://doi.org/10.1007/164_2018_178"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/164_2018_178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1109757023", 
          "https://doi.org/10.1007/164_2018_178"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-13", 
    "datePublishedReg": "2019-04-13", 
    "description": "RATIONALE: The underlying pharmacological mechanisms of mephedrone, especially as related to interactions with different neurotransmitter systems, are a critical area of study as mephedrone continues to be abused.\nOBJECTIVE: Direct-acting 5-HT2A/2C receptor agonists and antagonists and D1-3 receptor antagonists were examined in two groups of rats trained to discriminate mephedrone. A high dose of mephedrone was trained to extend previous results with traditional monoamine transporter inhibitors and substrate releasers. A very low dose of mephedrone was trained to preferentially capture serotonergic activity and to minimize the influence of rate-decreasing effects on substitution patterns. Selective 5-HT2A/2C and D1-3 receptor antagonists were examined in both groups.\nMETHODS: Male Sprague-Dawley rats were trained to discriminate either a low dose of 0.5\u00a0mg/kg mephedrone (N\u2009=\u200924) or a high dose of 3.2\u00a0mg/kg mephedrone (N\u2009=\u200911) from saline.\nRESULTS: In the low training-dose group, mephedrone, MDMA, methamphetamine, d-amphetamine, cocaine, and enantiomers of mephedrone substituted for mephedrone; mCPP partially substituted overall for mephedrone; and DOI, WAY163909, and morphine failed to substitute for mephedrone. In the high training-dose group, only mephedrone and MDMA substituted for mephedrone. Sulpiride produced a small antagonism of the low training dose of mephedrone while SCH23390, SB242084, and ketanserin altered response rates.\nCONCLUSIONS: A lower training dose of mephedrone produces a discriminative stimulus fully mimicked by MDMA, methamphetamine, cocaine, and d-amphetamine, whereas a higher training dose of mephedrone requires a discriminative stimulus that was only mimicked by MDMA. Dopaminergic or serotoninergic antagonists failed to produce significant blockade of mephedrone at either training dose.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00213-019-05241-z", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "type": "Periodical"
      }
    ], 
    "name": "Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00213-019-05241-z"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113380414"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7608025"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30980094"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00213-019-05241-z", 
      "https://app.dimensions.ai/details/publication/pub.1113380414"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-16T06:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000377_0000000377/records_106804_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00213-019-05241-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00213-019-05241-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00213-019-05241-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00213-019-05241-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00213-019-05241-z'


 

This table displays all metadata directly associated to this object as RDF triples.

204 TRIPLES      20 PREDICATES      60 URIs      16 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00213-019-05241-z schema:about anzsrc-for:11
2 anzsrc-for:1115
3 schema:author Nbac4fab7baf74b44a485577a9fcf4417
4 schema:citation sg:pub.10.1007/164_2018_178
5 sg:pub.10.1007/7854_2017_5
6 sg:pub.10.1007/bf02244073
7 sg:pub.10.1007/s00213-012-2855-1
8 sg:pub.10.1007/s00213-015-4142-4
9 sg:pub.10.1007/s00213-017-4716-4
10 sg:pub.10.1007/s002130050622
11 sg:pub.10.1038/npp.2011.304
12 https://doi.org/10.1016/0006-2952(84)90424-6
13 https://doi.org/10.1016/0014-2999(94)90690-4
14 https://doi.org/10.1016/j.bcp.2013.04.004
15 https://doi.org/10.1016/j.bcp.2014.01.024
16 https://doi.org/10.1016/j.drugalcdep.2012.04.021
17 https://doi.org/10.1016/j.drugalcdep.2017.04.024
18 https://doi.org/10.1016/j.euroneuro.2011.07.009
19 https://doi.org/10.1016/j.euroneuro.2014.04.009
20 https://doi.org/10.1016/j.euroneuro.2014.12.012
21 https://doi.org/10.1016/j.neuropharm.2015.01.003
22 https://doi.org/10.1016/j.neuropharm.2015.08.034
23 https://doi.org/10.1016/j.neuropharm.2017.04.006
24 https://doi.org/10.1016/j.neuropharm.2017.07.026
25 https://doi.org/10.1016/s0091-3057(03)00029-7
26 https://doi.org/10.1016/s0969-8051(02)00306-2
27 https://doi.org/10.1021/acschemneuro.7b00212
28 https://doi.org/10.1037/1064-1297.8.3.415
29 https://doi.org/10.1097/fbp.0000000000000328
30 https://doi.org/10.1097/fbp.0000000000000442
31 https://doi.org/10.1097/fbp.0b013e328364166d
32 https://doi.org/10.1111/adb.12399
33 https://doi.org/10.1111/bph.13030
34 https://doi.org/10.1111/j.1476-5381.2011.01499.x
35 https://doi.org/10.1111/j.1476-5381.2012.02145.x
36 https://doi.org/10.1124/jpet.111.184119
37 https://doi.org/10.1523/jneurosci.15-02-01308.1995
38 https://doi.org/10.3762/bjoc.8.194
39 https://doi.org/10.4303/jdar/236009
40 schema:datePublished 2019-04-13
41 schema:datePublishedReg 2019-04-13
42 schema:description RATIONALE: The underlying pharmacological mechanisms of mephedrone, especially as related to interactions with different neurotransmitter systems, are a critical area of study as mephedrone continues to be abused. OBJECTIVE: Direct-acting 5-HT2A/2C receptor agonists and antagonists and D1-3 receptor antagonists were examined in two groups of rats trained to discriminate mephedrone. A high dose of mephedrone was trained to extend previous results with traditional monoamine transporter inhibitors and substrate releasers. A very low dose of mephedrone was trained to preferentially capture serotonergic activity and to minimize the influence of rate-decreasing effects on substitution patterns. Selective 5-HT2A/2C and D1-3 receptor antagonists were examined in both groups. METHODS: Male Sprague-Dawley rats were trained to discriminate either a low dose of 0.5 mg/kg mephedrone (N = 24) or a high dose of 3.2 mg/kg mephedrone (N = 11) from saline. RESULTS: In the low training-dose group, mephedrone, MDMA, methamphetamine, d-amphetamine, cocaine, and enantiomers of mephedrone substituted for mephedrone; mCPP partially substituted overall for mephedrone; and DOI, WAY163909, and morphine failed to substitute for mephedrone. In the high training-dose group, only mephedrone and MDMA substituted for mephedrone. Sulpiride produced a small antagonism of the low training dose of mephedrone while SCH23390, SB242084, and ketanserin altered response rates. CONCLUSIONS: A lower training dose of mephedrone produces a discriminative stimulus fully mimicked by MDMA, methamphetamine, cocaine, and d-amphetamine, whereas a higher training dose of mephedrone requires a discriminative stimulus that was only mimicked by MDMA. Dopaminergic or serotoninergic antagonists failed to produce significant blockade of mephedrone at either training dose.
43 schema:genre research_article
44 schema:inLanguage en
45 schema:isAccessibleForFree false
46 schema:isPartOf sg:journal.1085440
47 schema:name Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.
48 schema:productId N68bd9639a42c4aecb867ec68f52b2de8
49 N893be12466b2467e87e53769d421218c
50 N973e4528feaf4f7081865d5422fa4a4b
51 Nf36b3f5a9851415cbfed7a0d06c121d7
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113380414
53 https://doi.org/10.1007/s00213-019-05241-z
54 schema:sdDatePublished 2019-04-16T06:21
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher Ne1d6d3a421e04dfb9ecc39b58ef1097f
57 schema:url http://link.springer.com/10.1007/s00213-019-05241-z
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N1500d1b6df82430fa2a95205f662f50c schema:affiliation https://www.grid.ac/institutes/grid.264727.2
62 schema:familyName Milewski
63 schema:givenName Andrew
64 rdf:type schema:Person
65 N4b93cb5aec3941e8906003912e506267 rdf:first N60b35940f9ff4fe483607aa9416ab4d1
66 rdf:rest N6024eba8c741482e830d9df6e8feda8d
67 N5f16efb1a76d4b5fa9ac07515d07e362 schema:affiliation https://www.grid.ac/institutes/grid.264727.2
68 schema:familyName Walker
69 schema:givenName Ellen A
70 rdf:type schema:Person
71 N6024eba8c741482e830d9df6e8feda8d rdf:first N7fffe613d5c24e84861158509560f2c8
72 rdf:rest N97cc667c6a074b6897a174436e232916
73 N60b35940f9ff4fe483607aa9416ab4d1 schema:affiliation https://www.grid.ac/institutes/grid.421568.c
74 schema:familyName Reitz
75 schema:givenName Allen B
76 rdf:type schema:Person
77 N68bd9639a42c4aecb867ec68f52b2de8 schema:name pubmed_id
78 schema:value 30980094
79 rdf:type schema:PropertyValue
80 N7538832cc8e84d40af270ab6ee61154f schema:affiliation https://www.grid.ac/institutes/grid.264727.2
81 schema:familyName Saber
82 schema:givenName Iman
83 rdf:type schema:Person
84 N7fffe613d5c24e84861158509560f2c8 schema:affiliation https://www.grid.ac/institutes/grid.264727.2
85 schema:familyName Rawls
86 schema:givenName Scott M
87 rdf:type schema:Person
88 N893be12466b2467e87e53769d421218c schema:name doi
89 schema:value 10.1007/s00213-019-05241-z
90 rdf:type schema:PropertyValue
91 N973e4528feaf4f7081865d5422fa4a4b schema:name dimensions_id
92 schema:value pub.1113380414
93 rdf:type schema:PropertyValue
94 N97cc667c6a074b6897a174436e232916 rdf:first N5f16efb1a76d4b5fa9ac07515d07e362
95 rdf:rest rdf:nil
96 Na06faf0ea2b64bc89db9d626c05f54d0 rdf:first N1500d1b6df82430fa2a95205f662f50c
97 rdf:rest N4b93cb5aec3941e8906003912e506267
98 Nbac4fab7baf74b44a485577a9fcf4417 rdf:first N7538832cc8e84d40af270ab6ee61154f
99 rdf:rest Na06faf0ea2b64bc89db9d626c05f54d0
100 Ne1d6d3a421e04dfb9ecc39b58ef1097f schema:name Springer Nature - SN SciGraph project
101 rdf:type schema:Organization
102 Nf36b3f5a9851415cbfed7a0d06c121d7 schema:name nlm_unique_id
103 schema:value 7608025
104 rdf:type schema:PropertyValue
105 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
106 schema:name Medical and Health Sciences
107 rdf:type schema:DefinedTerm
108 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
109 schema:name Pharmacology and Pharmaceutical Sciences
110 rdf:type schema:DefinedTerm
111 sg:journal.1085440 schema:issn 0033-3158
112 1432-2072
113 schema:name Psychopharmacology
114 rdf:type schema:Periodical
115 sg:pub.10.1007/164_2018_178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1109757023
116 https://doi.org/10.1007/164_2018_178
117 rdf:type schema:CreativeWork
118 sg:pub.10.1007/7854_2017_5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084506667
119 https://doi.org/10.1007/7854_2017_5
120 rdf:type schema:CreativeWork
121 sg:pub.10.1007/bf02244073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020914677
122 https://doi.org/10.1007/bf02244073
123 rdf:type schema:CreativeWork
124 sg:pub.10.1007/s00213-012-2855-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015284260
125 https://doi.org/10.1007/s00213-012-2855-1
126 rdf:type schema:CreativeWork
127 sg:pub.10.1007/s00213-015-4142-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024575806
128 https://doi.org/10.1007/s00213-015-4142-4
129 rdf:type schema:CreativeWork
130 sg:pub.10.1007/s00213-017-4716-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091221773
131 https://doi.org/10.1007/s00213-017-4716-4
132 rdf:type schema:CreativeWork
133 sg:pub.10.1007/s002130050622 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034947421
134 https://doi.org/10.1007/s002130050622
135 rdf:type schema:CreativeWork
136 sg:pub.10.1038/npp.2011.304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044856319
137 https://doi.org/10.1038/npp.2011.304
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/0006-2952(84)90424-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045071163
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/0014-2999(94)90690-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037141728
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.bcp.2013.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038605497
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.bcp.2014.01.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042885818
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/j.drugalcdep.2012.04.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003806071
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.drugalcdep.2017.04.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1086021993
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.euroneuro.2011.07.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030590514
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.euroneuro.2014.04.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024896051
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.euroneuro.2014.12.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038862287
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.neuropharm.2015.01.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028679944
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/j.neuropharm.2015.08.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035248661
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/j.neuropharm.2017.04.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084533479
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/j.neuropharm.2017.07.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090903492
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1016/s0091-3057(03)00029-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040651277
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1016/s0969-8051(02)00306-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003130359
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1021/acschemneuro.7b00212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091615896
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1037/1064-1297.8.3.415 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008053491
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1097/fbp.0000000000000328 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090659426
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1097/fbp.0000000000000442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106913628
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1097/fbp.0b013e328364166d schema:sameAs https://app.dimensions.ai/details/publication/pub.1017968100
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1111/adb.12399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038449511
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1111/bph.13030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046444836
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1111/j.1476-5381.2011.01499.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037674586
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1111/j.1476-5381.2012.02145.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050947391
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1124/jpet.111.184119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042124366
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1523/jneurosci.15-02-01308.1995 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082543491
190 rdf:type schema:CreativeWork
191 https://doi.org/10.3762/bjoc.8.194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071380882
192 rdf:type schema:CreativeWork
193 https://doi.org/10.4303/jdar/236009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072445071
194 rdf:type schema:CreativeWork
195 https://www.grid.ac/institutes/grid.264727.2 schema:alternateName Temple University
196 schema:name Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
197 Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. ellen.walker@temple.edu.
198 Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA, 19140, USA.
199 Department of Pharmaceutical Sciences, School of Pharmacy, Temple University, 3307 North Broad Street, Philadelphia, PA, 19140, USA. ellen.walker@temple.edu.
200 Department of Pharmacology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
201 rdf:type schema:Organization
202 https://www.grid.ac/institutes/grid.421568.c schema:alternateName Fox Chase Chemical Diversity Center
203 schema:name Fox Chase Chemical Diversity Center, Inc., Doylestown, PA, USA.
204 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...